Skip to main content

Table 1 Baseline clinical characteristics of patients according to tertiles of triglyceride-glucose index

From: The triglyceride-glucose index predicts 1-year major adverse cardiovascular events in end-stage renal disease patients with coronary artery disease

Characteristic

Total

N = 959

Tertile 1, ≤ 8.77

N = 320

Tertile 2, 8.77–9.40

N = 319

Tertile 3, > 9.40

N = 320

P value

Age, mean (SD), years

61.8 (10.5)

62.3 (10.9)

60.8 (10.5)

62.4 (9.9)

0.080

Male, No. (%)

715 (74.6)

246 (76.9)

235 (73.7)

234 (73.1)

0.500

SBP, mean (SD), mmHg

141.6 (25.0)

142.6 (24.7)

142.6 (24.7)

139.6 (25.5)

0.206

DBP, mean (SD), mmHg

78.7 (13.4)

79.6 (13.4)

79.4 (13.6)

77.2 (13.1)

0.046

Heart rate, mean (SD), beats/min

80.5 (14.7)

78.8 (13.9)

81.0 (15.7)

81.7 (14.3)

0.034

Medical history and risk factors, No. (%)

    

 Hypertension

890 (92.8)

288 (90.0)

303 (95.0)

299 (93.4)

0.044

 Diabetes mellitus

509 (53.1)

116 (36.2)

165 (51.7)

228 (71.2)

 < 0.001

 Current smoker

181 (18.9)

65 (20.3)

56 (17.6)

60 (18.8)

0.671

 Atrial fibrillation

81 (8.4)

26 (8.1)

27 (8.5)

28 (8.8)

0.960

 Cerebrovascular disease

184 (19.2)

61 (19.1)

59 (18.5)

64 (20.0)

0.888

 Valvular disease

31 (3.2)

13 (4.1)

12 (3.8)

6 (1.9)

0.237

 Peripheral arterial disease

95 (9.9)

29 (9.1)

29 (9.1)

37 (11.6)

0.478

Cause of ESRD, No. (%)

    

 < 0.001

 Diabetes mellitus

304 (31.7)

67 (20.9)

100 (31.3)

137 (42.8)

 

 Hypertension

123 (12.8)

55 (17.2)

39 (12.2)

29 (9.1)

 

 Glomerulonephritis

230 (24.0)

102 (31.9)

68 (21.3)

60 (18.8)

 

 Other/unknown

302 (31.5)

96 (30.0)

112 (35.1)

94 (29.4)

 

Insulin therapy, No. (%)

322 (33.6)

65 (20.3)

102 (32.0)

155 (48.4)

 < 0.001

Dialysis modality, No. (%)

    

0.065

 Hemodialysis

887 (92.5)

300 (93.8)

300 (94.0)

287 (89.7)

 

 Peritoneal dialysis

72 (7.5)

20 (6.2)

19 (6.0)

33 (10.3)

 

Vintage, years

    

0.624

 < 1

199 (20.8)

69 (21.6)

62 (19.4)

68 (21.2)

 

 1–5

444 (46.3)

141 (44.1)

147 (46.1)

156 (48.8)

 

 5–10

248 (25.9)

83 (25.9)

91 (28.5)

74 (23.1)

 

 ≥ 10

68 (7.1)

27 (8.4)

19 (6.0)

22 (6.9)

 

Index presentation, No. (%)

    

0.292

 AMI

564 (58.8)

177 (55.3)

192 (60.2)

195 (60.9)

 

 Non-AMI

395 (41.2)

143 (44.7)

127 (39.8)

125 (39.1)

 

Hemoglobin, g/L

105.5 (19.8)

104.7 (19.0)

106.0 (19.2)

105.7 (21.2)

0.668

Glucose, mmol/L

6.4 [4.8, 9.3]

4.7 [4.2, 5.7]

6.3 [5.0, 8.0]

10.0 [7.3, 13.5]

 < 0.001

Serum creatinine, mg/dl

8.7 [6.7, 10.9]

8.5 [6.9, 10.5]

9.2 [7.2, 11.7]

8.0 [6.2, 10.5]

0.001

TG, mmol/L

1.6 [1.1, 2.3]

1.0 [0.8, 1.3]

1.7 [1.4, 2.1]

2.5 [1.9, 3.4]

 < 0.001

TC, mmol/L

3.7 [3.1, 4.5]

3.5 [2.9, 4.1]

3.6 [3.2, 4.4]

4.1 [3.2, 4.9]

 < 0.001

HDL-C, mmol/L

0.9 [0.7, 1.1]

1.0 [0.8, 1.2]

0.8 [0.7, 1.1]

0.8 [0.7, 1.0]

 < 0.001

LDL-C, mmol/L

2.2 [1.7, 2.8]

2.1 [1.6, 2.5]

2.2 [1.7, 2.8]

2.3 [1.7, 3.0]

0.001

TyG index

9.1 [8.6, 9.6]

8.3 [8.1, 8.6]

9.1 [8.9, 9.2]

9.8 [9.6, 10.1]

 < 0.001

Procedure characteristic, No. (%)

     

 Radial access

740 (77.2)

241 (75.3)

249 (78.1)

250 (78.1)

0.627

 Extent of disease

     

  Any left main disease

111 (11.6)

32 (10.0)

44 (13.8)

35 (10.9)

0.296

  2-vessel disease

263 (27.4)

85 (26.6)

82 (25.7)

96 (30.0)

0.436

  3-vessel disease

544 (56.7)

169 (52.8)

184 (57.7)

191 (59.7)

0.196

 Moderate or severe calcification

432 (45.0)

141 (44.1)

149 (46.7)

142 (44.4)

0.764

 PCI treatment

676 (70.5)

218 (68.1)

225 (70.5)

233 (72.8)

0.429

Discharge medications, No. (%)

     

 Dual antiplatelet therapy

836 (87.2)

277 (86.6)

286 (89.7)

273 (85.3)

0.240

 ACE inhibitor or ARB

441 (46.0)

160 (50.0)

142 (44.5)

139 (43.4)

0.203

 Beta-blocker

775 (80.8)

248 (77.5)

261 (81.8)

266 (83.1)

0.167

 Calcium-channel blocker

620 (64.7)

220 (68.8)

206 (64.6)

194 (60.6)

0.099

 Statin

899 (93.7)

296 (92.5)

302 (94.7)

301 (94.1)

0.505

  1. Data are presented as mean (SD) or n (%)
  2. ACE, angiotensin-converting enzyme; AMI, acute myocardial infarction; ARB, angiotensin receptor blocker; DBP, diastolic blood pressure; ESRD, end-stage renal disease; HDL-C, high-density lipoprotein cholesterol; LDL-C, low-density lipoprotein cholesterol; PCI, percutaneous coronary intervention; SBP, systolic blood pressure; TC, total cholesterol; TG, triglycerides; TyG, triglyceride-glucose